Canine ehrlichiosis vaccine developed in Israel

01/2/2013 | Israel21c

Veterinary researchers in Israel have developed the first vaccine for canine monocytic ehrlichiosis, a potentially deadly tick-borne disease that affects dogs. Although more research is needed to ensure that the vaccine protects against other strains, a commercial vaccine will likely be developed.

View Full Article in:

Israel21c

Published in Brief:

SmartBrief Job Listings for Retail

Job Title Company Location
Analyst, Store Strategy and Method Improvements
Ross Stores, Inc
Dublin, California
Product Manager
Smithsonian Museum Retail
Washington, Dist. Columbia
Mgr of Merchandising and Supply Chain Systems
BJ's Wholesale Club
Westborough, Massachusetts
communications program manager, Partner Resources-Seattle, WA
Starbucks
Seattle, Washington
director, mobile engineering, Global Technology - Seattle, WA
Starbucks
Seattle, Washington